About Cellazon Inc.
Our Mission
Our Expertise
Our Expertise
At Cellazon Inc., our mission is to help improve drug approvals through patient-centric discovery of novel therapeutic targets and biomarkers.
Our Expertise
Our Expertise
Our Expertise
Cellazon is building high-resolution cell-to-cell communication maps directly from patient samples to uncover disease and cohort specific novel drug targets and biomarkers for precision therapy.
Strength: Uncover, known & unknown, cell signaling pathways using biostatistical analysis directly from patient samples first and then use AI/ML
Cellazon is building high-resolution cell-to-cell communication maps directly from patient samples to uncover disease and cohort specific novel drug targets and biomarkers for precision therapy.
Strength: Uncover, known & unknown, cell signaling pathways using biostatistical analysis directly from patient samples first and then use AI/ML models to define high value targets and therapies across patient cohorts or disease.
Differentiation: Unlike AI-first discovery companies, no dependence on large , pre-curated training datasets or model systems. Instead, capture the true complexity of human biology at the source using system biology.
Our Clients
Our Expertise
Our Clients
We have successfully collaborated with a major medical institution as well as a therapeutic company demonstrating how PathwayPersona (TM) can fit into therapeutic development process.
Leadership & Scientific Advisory Board Members
